Cancer Molecular Diagnostics Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 19
SKU : PH2791
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Cancer Molecular Diagnostics Market?
The Cancer Molecular Diagnostics market is expected to grow at a CAGR of 6.30% during the forecast period 2024-2031.
Who are the key players in Cancer Molecular Diagnostics Market?
Key Players are Abbott Laboratories, Bayer Healthcare, Becton Dickinson, Cepheid, Dako, Danaher Corporation, Qiagen N.V., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Beckman Coulter, bioMérieux, bioTheranostics, Genera Biosystems, Genomic Health, Genomix Biotech, Nuvera Bioscience and Orion Genomics.
Related Reports
pharmaceuticals

Europe Ovarian Cancer Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 25
Starting from

$3750

pharmaceuticals

Europe Liver Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 05
Starting from

$3750

pharmaceuticals

Salivary Gland Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 04
Starting from

$4350

pharmaceuticals

Lung Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 27
Starting from

$4350

pharmaceuticals

Urinary Tract Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 06
Starting from

$4350

pharmaceuticals

Triple Negative Breast Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 22
Starting from

$4350